Heritage Trust’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
JCI
BC
TNB
WAM
IAIM
Heritage Trust's BMY.RT Position: Q1 2021 in Review
Heritage Trust sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 13,014 shares — an estimated $9K sold.
Heritage Trust first reported a position in BMY.RT in Q2 2020 and held it in 3 quarters. The position peaked at $47K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.
- Heritage Trust reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
- Heritage Trust sold 13,014 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $9K.
- Heritage Trust first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020 and held it in 3 quarters.
- Heritage Trust's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $47K in Q2 2020.
- 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.
Based on Heritage Trust's 13F filing for Q1 2021, filed 12 May 2021.